InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,316.05
(
1.15%
)
Post# of 113280
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

smallcapvoice

Send PM Follow Ignore
Followers 17
Posts 273
Boards Moderated 0
Alias Born 08/20/2002

smallcapvoice

Re: None

Wednesday, 02/07/2024 3:38:08 PM

Wednesday, February 07, 2024 3:38:08 PM

Post# of 113280
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

https://finance.yahoo.com/news/briacell-announces-strong-clinical-data-130000153.html

Disease control rate of 61% observed in evaluable Phase 2 patients treated with the same formulation in BriaCell’s pivotal Phase 3 study

Disease control rate of 50% in evaluable patients treated with the Phase 3 formulation who failed prior antibody-drug conjugate (ADC) therapy

Notable responder had failed 4 prior therapies including ADC therapy with metastatic liver tumor “no longer observed” following BriaCell treatment
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up